OrbiMed’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,028,354	Closed	-$30.5M	–	163
2018 Q3	$30.5M	Sell	3,028,354 -483,190	-14%	-$3.85M	0.37%	70
2018 Q2	$25.4M	Hold	3,511,544	–	–	0.31%	73
2018 Q1	$21.2M	Sell	3,511,544 -1,895,300	-35%	-$15.6M	0.26%	79
2017 Q4	$52M	Sell	5,406,844 -764,596	-12%	-$5M	0.66%	47
2017 Q3	$54.8M	Hold	6,171,440	–	–	0.53%	59
2017 Q2	$78.1M	Buy	6,171,440 +100,000	+2%	+$1.18M	0.82%	40
2017 Q1	$63.8M	Hold	6,071,440	–	–	0.73%	44
2016 Q4	$55.9M	Buy	6,071,440 +569,200	+10%	+$6.43M	0.72%	42
2016 Q3	$64.9M	Buy	5,502,240 +814,000	+17%	+$12.4M	0.74%	50
2016 Q2	$60.7M	Buy	4,688,240 +130,500	+3%	+$1.9M	0.64%	47
2016 Q1	$72.9M	Buy	4,557,740 +191,000	+4%	+$3.63M	0.77%	40
2015 Q4	$125M	Buy	4,366,740 +284,940	+7%	+$7.89M	1.13%	31
2015 Q3	$116M	Buy	4,081,800 +1,458,800	+56%	+$53.7M	1.17%	30
2015 Q2	$94.2M	Buy	2,623,000 +136,600	+5%	+$4.25M	0.8%	38
2015 Q1	$72.3M	Hold	2,486,400	–	–	0.63%	46
2014 Q4	$52.4M	Buy	2,486,400 +1,015,200	+69%	+$20.1M	0.51%	47
2014 Q3	$28.5M	Buy	+1,471,200	New	+$23.1M	0.31%	61